Multiple Myeloma - Survival Rate Statistics by Hospital
  • Home
  • Higher Risk Myeloma
  • Myeloma Blog
  • Myeloma Specialists Listing
  • Doctor Submissions
  • Contact Us

Myeloma Civil War - High Cost of Cancer Drugs!

3/26/2016

2 Comments

 
I have to begin this discussion letting the readers know that I love my myeloma drug dealers.  Without Thalamid and Velcade, I would not be writing this blog post today.  I am alive because these game changing drugs were part of the regimen which has keep me alive for the past 10 years.   In addition, I had great insurance which my wife had with her job in the school district, and Medicare was a backup, so I seldom had to pay anything myself.  I once told one of the drug manufactures which supported our IMF meeting, "I do not care how much the drugs cost as long as I do not have to pay for them."   Recently I have watched two outstanding myeloma doctors from Mayo Clinic have a civil debate on twitter about the high cost of cancer drugs. I admire them both.   Dr. Rajkumar has taken the position that cancer drugs are outrageously priced and older drugs should not go up more than the increase in the cost of living index.  He is so right, and any thing more is a ripoff.  Dr Fonseca will argue without the profit motive to develop new drugs, there would be no new drugs for orphan diseases like myeloma or orphan diseases in general.  He is so right, and I am still alive because of this new drug development.  So how can these two terribly divergent views coexist and both be right.  I think they both have merit.  I will outline my thoughts on each in future posts.

Dr. Rajkumar is right for the following reasons:

1) Old drugs like Gleevex(Novaris) and Melphalan(GlaxoSmithKline) have had outrageous price increases over time. CLICK HERE or HERE
2) Drug companies cry high costs of R&D, yet prices are similar for high and low volume diseases. Fixed costs like R&D go down linearly with volume.  So for all of the most common cancers,  patients with breast, colon, and lung cancer are getting totally ripped off.

Dr. Fonseca is right for the following reason:

1) Profit is the only driver for Pharma companies for the development of new game changing drugs. Government and non profit cancer organizations try but are sadly incapable of properly funding cancer research, therefore Pharma must fill this gap. 

How can both of them be right.  I believe they are both correct, however sometimes, and I think that sometimes is now, government needs to make sure the playing field is level.  My original statement was, "Save me as long as I do not have to pay!"  Unfortunately some people can not pay for the out of control drug price increases.  It reminds me of an old skit by Jack Benny "Your Money Or Your LIFE?" because when someone has this kind of control over your life and death, I say that is a monopoly and the government has laws for that. 

For more information on multiple myeloma CLICK HERE and you can follow me on twitter at: https://twitter.com/grpetersen1
2 Comments
David Langston
3/27/2016 01:46:24 pm

Gary, you should really do a commentary about myeloma-caused renal failure and dialysis. Right now the five-year survival rate for meyloma is probably 48% or higher and improving annually, but the survival rate for a non-myeloma dialysis patient is about 33-37% and it hasn't improved in decades. So based on those statistics, myeloma survival is relatively easy compared to surviving dialysis. Other statistics I've read suggest that 10% of myeloma patients have kidney failure on presentation and 10% more lose their kidneys during the course of their disease.

From what I've seen, all other myeloma patient advocate sites simply ignore patients with renal failure. Maybe we are too rare for them. Maybe we are expected to be so short lived that it is too much bother to cover the subject.

Reply
Gary Petersen link
3/28/2016 05:47:57 am

David, you just opened my eyes to the very low survival for non myeloma dialysis dependent patients. I know the prognosis was terrible for myeloma patients, I just had no idea it was that low for non myeloma dialysis patients. I will put this on my "To Do List". I remember when I was diagnosed 10 years ago prior to use of Velcade and high cut off hemodialysis the average life expectancy of a myeloma patient with dialysis depended kidney failure was just 3 MONTHS.

Reply

Your comment will be posted after it is approved.


Leave a Reply.

    Author

    Gary R. Petersen
    [email protected]
    CLICK HERE for my myeloma journey

    ©2012 All Rights Reserved

    Categories

    All

    Archives

    January 2025
    August 2023
    March 2023
    October 2022
    February 2021
    October 2020
    September 2020
    August 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    August 2018
    June 2018
    May 2018
    April 2018
    January 2018
    November 2017
    October 2017
    September 2017
    August 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    November 2013
    October 2013
    September 2013
    August 2013
    July 2013
    June 2013
    May 2013
    April 2013
    March 2013
    February 2013
    January 2013
    December 2012
    November 2012
    October 2012
    September 2012
    August 2012
    July 2012
    June 2012
    May 2012
    April 2012
    March 2012

    RSS Feed

Web Hosting by iPage